managed dsip ii equity strategy 2026 Private insights and data snapshots Separating Apples from Pears ·
Separating Apples from Pears The Hedge Fund Journal A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked Private Equity Data Management Software Semarchy Diversity, Equity & Inclusion DS Smith Private Equity Investment Lifecycle
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



